57 related articles for article (PubMed ID: 22275346)
1. Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinations.
Westekemper H; Freistuehler M; Anastassiou G; Nareyeck G; Bornfeld N; Steuhl KP; Scheulen ME; Hilger RA
Br J Ophthalmol; 2012 Apr; 96(4):591-6. PubMed ID: 22275346
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.
Westekemper H; Freistuehler M; Bornfeld N; Steuhl KP; Scheulen M; Hilger RA
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):279-84. PubMed ID: 22782301
[TBL] [Abstract][Full Text] [Related]
3. B-Raf inhibition in conjunctival melanoma cell lines with PLX 4720.
Riechardt AI; Maier AK; Nonnenmacher A; Reichhart N; Keilholz U; Kociok N; Strauss O; Joussen AM; Gundlach E
Br J Ophthalmol; 2015 Dec; 99(12):1739-45. PubMed ID: 26347528
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
Westekemper H; Freistuehler M; Anastassiou G; Nareyeck G; Zeschnigk M; Bornfeld N; Steuhl KP; Scheulen ME; Hilger RA
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):78-80. PubMed ID: 21176737
[No Abstract] [Full Text] [Related]
5. Single-Walled Carbon Nanohorns Inhibit Proliferation of Conjunctival Melanoma Cell Lines CRMM-1 and Involved in Energy Metabolism.
Cao Y; Zhang Y; Zhao M
J Nanosci Nanotechnol; 2015 Feb; 15(2):1821-30. PubMed ID: 26353738
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Ditta LC; Shildkrot Y; Wilson MW
Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
[TBL] [Abstract][Full Text] [Related]
7. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
9. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
11. [Mitomycin C in diffuse multilocal malignant conjunctival melanoma].
Hoyer A; Raiskup F; Pillunat E
Klin Monbl Augenheilkd; 2010 May; 227(5):430-2. PubMed ID: 20490999
[No Abstract] [Full Text] [Related]
12. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
13. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
14. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanoma and electrochemotherapy: preliminary results using 2D and 3D cell culture models in vitro.
Fiorentzis M; Katopodis P; Kalirai H; Seitz B; Viestenz A; Coupland SE
Acta Ophthalmol; 2019 Jun; 97(4):e632-e640. PubMed ID: 30548215
[TBL] [Abstract][Full Text] [Related]
16. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
17. The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
Knight LA; Di Nicolantonio F; Whitehouse PA; Mercer SJ; Sharma S; Glaysher S; Hungerford JL; Hurren J; Lamont A; Cree IA
Anticancer Drugs; 2006 Jul; 17(6):649-55. PubMed ID: 16917210
[TBL] [Abstract][Full Text] [Related]
18. [Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Pan XY; Li FQ; Yu RJ; Xie GF; Wang H; Zhao LY; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):15-8. PubMed ID: 2843330
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
20. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
